Retraction for Wang et al., Hypertension 35 (1) 202-208.
Retraction for Gelband et al., Hypertension 35 (1) 209-213.

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

(Hypertension. 2002;40:566.)
© 2002 American Heart Association, Inc.

Retraction

An extract of the first 100% of the full text is provided, because this article has no abstract.

Angiotensin I–Converting Enzyme Antisense Gene Therapy Causes Permanent Antihypertensive Effects in Spontaneously Hypertensive Rats

Angiotensin I–Converting Enzyme Antisense Prevents Altered Renal Vascular Reactivity, But Not High Blood Pressure, in Spontaneously Hypertensive Rats

In January 2000, Hypertension published 2 articles on Angiotensin I–Converting Enzyme Antisense from the Department of Physiology, University of Florida College of Medicine. At the request of the corresponding author, Hypertension has retracted the following 2 articles from publication:

Wang H, Reaves PY, Gardon ML, Keene K, Goldberg DS, Gelband CH, Katovich MJ, Raizada MK. Angiotensin I–converting enzyme antisense gene therapy causes permanent antihypertensive effects in spontaneously hypertensive rats. Hypertension. 2000;35(pt 2):202–208.

Gelband CH, Wang H, Gardon ML, Keene K, Goldberg DS, Reaves PY, Katovich MJ, Raizada MK. Angiotensin I–converting enzyme antisense prevents altered renal vascular reactivity, but not high blood pressure, in spontaneously hypertensive rats. Hypertension. 2000;35(pt 2):209—213.